Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 11, 2002, Pages 1571-1576

  Kettering, Klaus ^a   Mewis, Christian ^a   Dörnberger, Volker ^a   Vonthein, Reinhard ^a   Bosch, Ralph F ^a   Kühlkamp, Volker ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Defibrillators; Implantable; Metoprolol; Sotalol; Tachycardia; Ventricular; Ventricular fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT; METOPROLOL TARTRATE; SOTALOL;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL; TREATMENT OUTCOME; VERTIGO;

EID: 0036854440     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01571.x     Document Type: Article

References (18)

1. Moss A, Hall W, Cannom D, et al Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940.
2. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The cardiac arrest study Hamburg (CASH). Circulation 2000; 102:748-754.
3. The Antiarrhythmic versus Implantable Defibrillators [AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
4. Conolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study [CIDS). A randomized trial of implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
5. Santini M, Pandozi C, Ricci R. Combining antiarrhythmic drugs and implantable devices therapy: Benefits and outcome. J Interven Card Electrophysiol 2000; 4:65-68.
6. Dorian P. Combination ICD and drug treatments - Best options. Resuscitation 2000; 45:S3-S6.
7. Kühlkamp V, Mewis C, Mermi J, et al. Suppression of sustained ventricular tachyarrhythmias: A comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol 1999; 33:46-52.
8. Seidl K, Hauer B, Schwick N, et al. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol 1998; 82:744-748.
9. Antz M, Cappato R, Kuck KH. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. J Cardiovasc Pharmacol 1995; 26:627-635.
10. Kovoor P, Yung A, Byth K, et al. Comparison of the long-term efficacy of implantable defibrillators and sotalol for documented spontaneous sustained ventricular tachyarrhythmias secondary to coronary artery disease. Aust NZ Med 1999; 29:331-341.
11. Nademanee K, Feld G, Hendrickson J, et al. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation 1985; 72:555-564.
12. Dolack GL, for the CASCADE investigators. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Am J Cardiol 1994; 73:237-241.
13. Pacifico A, Hohenloser S, Williams J, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999; 340:1855-1862.
14. Mewis C, Kühlkamp V, Mermi J, et al. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias. J Am Coll Cardiol 1999; 33:1989-1995.
15. Mason JW, for the electrophysiologic study versus electrocardiographic monitoring investigators investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993; 329:445-451.
16. Nademanee K, Taylor R, Bailey WE, et al. Treating electrical storm. Sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000; 102:742-747.
17. Kühlkamp V, Mermi J, Mewis C, et al. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. J Cardiovasc Pharmacol 1997; 29:373-381.
18. The cardiac arrhythmia suppression trial (CAST) investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406-412.